DrugRepV_0338 | Niclosamide | Antiparasitic products, Insectisides and Repellents | Tapeworm and intestinal fluke infections | Helminthiasis | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0339 | Mebendazole | Antiparasitic products, Insectisides and Repellents | Helminthiasis (Enterobius vermicularis (pinworm), Trichuris trichiura (whipworm), Ascaris lumbricoides (common roundworm), Ancylostoma duodenale (common hookworm), Necator americanus (American hookworm) in single or mixed infections) | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved, Vet approved | 27622822 |
DrugRepV_0340 | Amiodarone | Cardiovascular agents | Anginal and Arrhythmia | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0341 | Procainamide | Cardiovascular agents | Ventricular arrhythmias | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0342 | Azithromycin | Antiinfectives For Systemic Use | Bacterial infections | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0343 | Chlortetracycline | Antiinfectives For Systemic Use | Bacterial infections | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0344 | Benztropine | Nervous System | Parkinson disease | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0345 | Chloroquine | Antiparasitic products, Insectisides and Repellents | Malaria | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0346 | Hydroxychloroquine | Antiparasitic products, Insectisides and Repellents | Malaria | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0347 | Amodiaquine | Antiparasitic products, Insectisides and Repellents | Malaria | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0348 | Bepridil | Cardiovascular agents | Hypertension and angina | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0349 | Vincristine | Antineoplastic and Immunomodulating Agents | Cancer (Acute leukemia |Hodgkin's and non-Hodgkin's lymphoma |Neuroblastoma |Rhabdomyosarcoma |Ewing's sarcoma |Wilms' tumor | Multiple myeloma | Chronic leukemias | Thyroid cancer | Brain tumors) | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0350 | Prochlorperazine | Nervous System | Nausea | Vomiting | Schizophrenia | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_0351 | Paroxetine | Nervous System | Major depressive disorder (MDD) | Panic disorder | Obsessive-compulsive disorder (OCD) | Social anxiety disorder (social phobia) | Generalized anxiety disorder (GAD) | Post-traumatic stress disorder (PTSD) | Premenstrual dysphoric disorder (PMDD) | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved, Investigational | 27622822 |
DrugRepV_0352 | Clomiphene | Genito Urinary System and Sex Hormones | Polycystic ovary syndrome | Ebola virus | Ebola Zaire glycoprotein pseudotype vesicular stomatitis virus | NA | Renilla luciferase assay | Decrease (50 %) | Approved | 27622822 |
DrugRepV_3061 | Abamectin | NA | Helmintic infection | Chikungunya virus | CHIKV-Rluc | NA | Renilla luciferase assay | No significant effect (No significant effect %) | Terminated | 26752081 |
DrugRepV_3062 | Amphotericin B | Antiinfectives For Systemic Use | Fungal infection | Chikungunya virus | CHIKV-Rluc | NA | Renilla luciferase assay | No significant effect (90 %) | Approved | 26752081 |
DrugRepV_3063 | Berberine | NA | Parasitic and fungal infection | Chikungunya virus | CHIKV-Rluc | NA | Renilla luciferase assay | No significant effect (No significant effect %) | Approved | 26752081 |
DrugRepV_3064 | Bromocriptine | Nervous System | Parkinson disease | Chikungunya virus | CHIKV-Rluc | NA | Renilla luciferase assay | No significant effect (3 %) | Approved | 26752081 |
DrugRepV_3065 | Cerivastatin | Cardiovascular agents | Rhabdomyolysis | Chikungunya virus | CHIKV-Rluc | NA | Renilla luciferase assay | No significant effect (10 %) | Approved | 26752081 |
DrugRepV_3857 | Clomiphene | Genito Urinary System and Sex Hormones | Polycystic ovary syndrome | Ebola virus | Mayinga | NA | Renilla luciferase assay | Decrease (100 %) | Approved | 27490565 |
DrugRepV_3858 | Enclomiphene | NA | Male hypogonadism | Ebola virus | Mayinga | NA | Renilla luciferase assay | Decrease (100 %) | Investigational | 27490565 |
DrugRepV_3859 | Zuclomiphene | NA | NA | Ebola virus | Mayinga | NA | Renilla luciferase assay | Decrease (100 %) | NA | 27490565 |
DrugRepV_5987 | Castanospermine | Antiviral | Dengue and Parainfluenza | Dengue virus | 16681-Replicon | | Renilla luciferase assay | Decrease | Experimental | 15994763 |
DrugRepV_6374 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6375 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-methyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6376 | (2S)-6-amino-2-[(2S)-2-[(4-{[(5Z)-3-butyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]-5-carbamimidamidopentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6377 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-cyclopentyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6378 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-cyclohexyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6379 | methyl 2-[(5Z)-5-[(4-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carbamoylpentyl]carbamoyl}pentyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}phenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]hexanoate | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6380 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-4-oxo-3-(prop-2-en-1-yl)-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6381 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-(2-hydroxyethyl)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6382 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-(4-methoxyphenyl)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6383 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-(4-chlorophenyl)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6384 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-[(4-methoxyphenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6385 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-[(4-chlorophenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6386 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-4-oxo-3-(2-phenylethyl)-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6387 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6388 | (2S)-6-amino-2-[(2S)-2-[(4-{[(5Z)-3-butyl-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]-5-carbamimidamidopentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6389 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-cyclopentyl-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6390 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-(2-hydroxyethyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6391 | (2S)-6-amino-2-[(2S)-2-[(4-{[(5Z)-3-benzyl-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]-5-carbamimidamidopentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6392 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-3-[(4-chlorophenyl)methyl]-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6393 | (2S)-6-amino-2-[(2S)-5-carbamimidamido-2-[(4-{[(5Z)-2,4-dioxo-3-(2-phenylethyl)-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]pentanamido]-N-[(1S)-1-carbamoylpentyl]hexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6394 | (2S)-N-[(4S,7S)-1-amino-7-{[1-(4-{[(5Z)-3-benzyl-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenyl)ethenyl]amino}-10-carbamimidamido-5,6-dioxodecan-4-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6395 | (2S)-N-[(5S,8S)-1-amino-11-carbamimidamido-6,7-dioxo-8-[(3-{[(5Z)-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]undecan-5-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6396 | (2S)-N-[(5S,8S)-1-amino-11-carbamimidamido-8-[(3-{[(5Z)-3-cyclopentyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl}phenyl)formamido]-6,7-dioxoundecan-5-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6397 | (2S)-N-[(5S,8S)-1-amino-11-carbamimidamido-8-[(2S)-2-[(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanamido]-6,7-dioxoundecan-5-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6398 | (2S)-N-[(5S,8S)-1-amino-11-carbamimidamido-8-(2-{3-[(4-methoxyphenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-yl}acetamido)-6,7-dioxoundecan-5-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_6399 | (2S)-N-[(5S,8S)-1-amino-11-carbamimidamido-8-{2-[(5Z)-3-[(4-methoxyphenyl)methyl]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]acetamido}-6,7-dioxoundecan-5-yl]-2-hydrazinylhexanamide | NA | NA | Dengue virus | NA | | Renilla luciferase assay | Decrease (50 %) | NA | 24083834 |
DrugRepV_7092 | Castanospermine | Antiviral | Dengue and Parainfluenza | West Nile virus | NY 1999-Replicon | | Renilla luciferase assay | No significant difference | Experimental | 15994763 |